Revolution Medicines Stock Investor Sentiment
| RVMD Stock | USD 40.29 0.39 0.98% |
About 66% of Revolution Medicines' investor base is looking to short. The analysis of the overall investor sentiment regarding Revolution Medicines suggests that many traders are alarmed. The current market sentiment, together with Revolution Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Revolution Medicines stock news signals to limit their universe of possible portfolio assets.
Revolution |
Revolution Medicines Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Revolution Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Revolution Medicines that are available to investors today. That information is available publicly through Revolution media outlets and privately through word of mouth or via Revolution internal channels. However, regardless of the origin, that massive amount of Revolution data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Revolution Medicines news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Revolution Medicines relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Revolution Medicines' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Revolution Medicines alpha.
Revolution Medicines Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 2022 shares by Mark Goldsmith of Revolution Medicines at 45.4566 subject to Rule 16b-3 | 10/25/2024 |
2 | Disposition of 5000 shares by Patel Sushil of Revolution Medicines at 24.84 subject to Rule 16b-3 | 10/31/2024 |
3 | Disposition of 5000 shares by Mark Goldsmith of Revolution Medicines at 55.0268 subject to Rule 16b-3 | 11/01/2024 |
4 | Disposition of 36600 shares by Mark Goldsmith of Revolution Medicines at 0.49 subject to Rule 16b-3 | 11/04/2024 |
5 | Revolution Medicines CEO Mark A. Goldsmith sells 3.88 million in stock | 11/05/2024 |
6 | Victory Capital Management Inc. Sells 104,851 Shares of Revolution Medicines, Inc. - MarketBeat | 11/19/2024 |
7 | Revolution Medicines Announces Pricing of Upsized 750.0 Million Public Offering of Common Stock and Pre-Funded Warrants | 12/04/2024 |
8 | Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and ... | 12/05/2024 |
9 | Verition Fund Management LLC Buys New Stake in Revolution Medicines, Inc. - MarketBeat | 12/11/2024 |
10 | Revolution Medicines SWOT analysis RAS inhibitor stock shows promise amid clinical trials | 12/16/2024 |
11 | Disposition of 50900 shares by Mark Goldsmith of Revolution Medicines at 4.09 subject to Rule 16b-3 | 01/03/2025 |
12 | UBS Group Raises Revolution Medicines Price Target to 71.00 | 01/08/2025 |
13 | Revolution Medicines, Inc. The Biotech Stock with Biggest Upside Potential | 01/17/2025 |
Complementary Tools for Revolution Stock analysis
When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |